| 产品名称： | Sporormiella australis (Spegazzini) Ahmed et Cain, teleomorph |
|---|---|
| 商品货号： | TS141791 |
| Strain Designations： | MF5672 |
| Application： | produces australifungin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 334: Oatmeal agar |
| Growth Conditions： | Temperature: 24.0°C Duration: under black and fluorescent lights |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Isolation： | moose dung, Superior Natl. Forest, MN |
| References： | Cabello A, et al. Antibiotic agents. US Patent 5,276,055 dated Jun 4 1994 Mandala SM, et al. The discovery of australifungin, a novel inhibitor of sphinganine N- acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. 48: 349-356, 1995. PubMed: 7797434 . . J. Org. Chem. 60: 1772-1776, 1995. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Sporormiella australis (Spegazzini) Ahmed et Cain, teleomorph |
|---|---|
| 商品货号： | TS141791 |
| Strain Designations： | MF5672 |
| Application： | produces australifungin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 334: Oatmeal agar |
| Growth Conditions： | Temperature: 24.0°C Duration: under black and fluorescent lights |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Isolation： | moose dung, Superior Natl. Forest, MN |
| References： | Cabello A, et al. Antibiotic agents. US Patent 5,276,055 dated Jun 4 1994 Mandala SM, et al. The discovery of australifungin, a novel inhibitor of sphinganine N- acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. 48: 349-356, 1995. PubMed: 7797434 . . J. Org. Chem. 60: 1772-1776, 1995. |
